Search results
Paula Ramos Sells 10,178 Shares of Kimberly-Clark Co. (NYSE:KMB) Stock
ETF DAILY NEWS· 6 days agoKimberly-Clark Co. (NYSE:KMB – Get Free Report) insider Paula Ramos sold 10,178 shares of the firm’s stock in a transaction that occurred on Wednesday, April 24th. Following the sale, the insider ...
Kimberly-Clark (NYSE:KMB) Shares Gap Up on Strong Earnings
ETF DAILY NEWS· 7 days agoKimberly-Clark Co. (NYSE:KMB – Get Free Report) gapped up prior to trading on Tuesday following a better than expected earnings announcement. Kimberly-Clark shares last traded at $136.02, with ...
Royal Bank of Canada Increases Kimberly-Clark (NYSE:KMB) Price Target to $126.00
ETF DAILY NEWS· 6 days agoKimberly-Clark (NYSE:KMB – Get Free Report) had its price target increased by research analysts at Royal Bank of Canada from $123.00 to $126.00 in a research report issued on Wednesday, Benzinga ...
Kimberly-Clark (NYSE:KMB) Given New $115.00 Price Target at Bank of America
ETF DAILY NEWS· 7 days agoKimberly-Clark (NYSE:KMB – Free Report) had its price objective boosted by Bank of America from $110.00 to $115.00 in a research note issued to investors on Wednesday morning, Benzinga reports ...
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology...
San Mateo Daily Journal· 2 days agoJaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome (SBS) with intestinal